Requires insurers to cover the substitution of a brand name prescription drug when the federal food and drug administration has declared that there is a supply issue with a generic drug

Summary

The bill forces health insurers and prescription‑drug providers in New York to cover a brand‑name version of a drug if the generic version listed on their formulary is unavailable because the FDA has identified a supply problem. Coverage must be at the same cost level as the generic until the shortage is fixed. This protects patients from interruptions in treatment.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share